Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Classical hematology 2Sarcoma 1Plasma cell 1Myeloid 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Febrile Neutropenia 2Neoplasms 1Fever 1

Interventions

Cyclophosphamide 93fludarabine phosphate 86Busulfan 63Cyclosporine 57Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53Epoetin Alfa 53Antilymphocyte Serum 43fludarabine 42Filgrastim 41Cytarabine 41Tacrolimus 39Melphalan 38Darbepoetin alfa 38Methotrexate 34Radiotherapy 32Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23Methylprednisolone 21Etoposide 21apixaban 18eltrombopag 16Thiotepa 16Dalteparin 16ferric carboxymaltose 14Daunorubicin 14Azacitidine 14Alemtuzumab 14thymoglobulin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Piperacillin, Tazobactam Drug Combination × Classical hematology × Clear all
NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Forest Laboratories

Phase 2 Terminated
2 enrolled 2 charts
Classical hematology

Neoplasms, Febrile Neutropenia

NCT02463747 2015-06-04

RR

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
110 enrolled
Classical hematology

Fever, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡